Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients
- 1 April 2010
- journal article
- case report
- Published by Elsevier in Neuromuscular Disorders
- Vol. 20 (4) , 251-254
- https://doi.org/10.1016/j.nmd.2010.01.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutationsHuman Mutation, 2009
- Local Dystrophin Restoration with Antisense Oligonucleotide PRO051New England Journal of Medicine, 2007
- Cognitive and Psychological Profile of Males With Becker Muscular DystrophyJournal of Child Neurology, 2007
- Impact de l'étude familiale sur le pronostic et le conseil génétique chez un enfant porteur d'une délétion des exons 50-51 du gène de la dystrophineArchives de Pédiatrie, 2007
- Copy number variation in the genome; the human DMD gene as an exampleCytogenetic and Genome Research, 2006
- Grandpa and I have Dystrophinopathy?: Approach to Asymptomatic HyperCKemiaPediatric Neurology, 2006
- Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patientsEuropean Journal of Paediatric Neurology, 2005
- Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletionsNeuropathology and Applied Neurobiology, 2004
- DMD and BMD in the same family due to two distinct mutationsAmerican Journal of Medical Genetics, 1995
- Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotypeJournal of the Neurological Sciences, 1995